BioSpace News Archive

Cerus Corporation announced today that the American Red Cross has received approval by the U.S. Food and Drug Administration for their first biologics license application for interstate distribution of platelets that have been pathogen-reduced with INTERCEPT Blood Systems.

Dan & Patti Hunt, Producers of the “In production” documentary “The Law of Attraction” launched an online course that could help reduce everyday stress.

Headquartered in Las Cruces, New Mexico, SameDay Security is a company that develops and sells electronic health monitoring and emergency response systems under the brands Electronic Caregiver and Addison Care

Perrigo Company plc (NYSE; TASE: PRGO) today announced the launch of an AB-rated generic version of Topicort® (desoximetasone)Topical Spray 0.25%

U.S. ARKRAY, Inc. (ARKRAY) announces partnership with Medline Industries, Inc. The company will distribute the ADAMS A1c HA-8180V fully automated HPLC HbA1c analyzer, AUTION MAX AX-4030 fully automated urine chemistry analyzer and AUTION ELEVEN AE-4022 semi-automated urine chemistry analyzer to Physician Office Laboratories (POL’s).

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has won the 2018 College of Healthcare Information Management Executives (CHIME) Foundation Partner Award.

MedShift, a leader in aesthetic medical equipment and technology, is excited to announce a five-year long strategic partnership with Merz North America.

- InterSystems, a global leader in information technology platforms for health, business and government applications, today announced that fast growing Australian medical technology company RxMx will expand its partnership with InterSystems to increase its agility in developing solutions that enhance the safe use of medicines.

Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, announced today a collaboration with Edwards Lifesciences focused on improving the detection of heart disease.

Vanda Pharmaceuticals Inc. today announced that HETLIOZ® (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical study.